What are the instructions for taking Naproxen (Nonsteroidal Anti-Inflammatory Drug)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Naproxen Administration Instructions

Naproxen should be taken at the lowest effective dose for the shortest duration consistent with individual treatment goals, with a standard dosage of 375-500 mg twice daily (every 12 hours) for prescription naproxen. 1, 2

Dosage Guidelines

  • For prescription naproxen, the recommended dose is 250 mg, 375 mg, or 500 mg twice daily, depending on the condition being treated 2
  • For over-the-counter naproxen sodium (Aleve), the equivalent dosage would be 440 mg (2 tablets of 220 mg) twice daily 1
  • Always take naproxen with food to minimize gastrointestinal side effects 3, 2
  • For acute pain management, start with 500 mg, followed by 500 mg every 12 hours or 250 mg every 6-8 hours as required, not exceeding 1250 mg on the first day and 1000 mg daily thereafter 2
  • For acute gout, begin with 750 mg followed by 250 mg every 8 hours until the attack subsides 2

Administration Timing

  • Morning and evening doses do not need to be equal in size 2
  • Taking naproxen more frequently than twice daily generally does not improve response due to its relatively long half-life 2, 4
  • For acute pain conditions where rapid onset is desired, naproxen sodium may be preferred over regular naproxen 2, 5

Duration of Treatment

  • Initial treatment should be for 2-4 weeks at the maximum tolerated and approved dosage 1
  • After 2-4 weeks, evaluate treatment response and consider tapering after 12 weeks of sustained response 1
  • Long-term use requires regular monitoring for adverse effects 3

Special Populations

  • For elderly patients, consider starting at a lower dose and adjusting based on response, although total plasma concentration remains unchanged 2
  • Dosage adjustments are generally not required for mild renal or hepatic impairment, but starting at a lower dose is prudent 2, 6
  • Naproxen is not recommended for patients with moderate to severe renal impairment (creatinine clearance <30 mL/min) 2

Monitoring and Precautions

  • Monitor for gastrointestinal side effects, which occur in 10-20% of patients 3
  • For patients at high risk of GI complications (age >60, history of peptic ulcer disease, concomitant use of anticoagulants or corticosteroids), consider gastroprotection with proton pump inhibitors 3
  • Monitor blood pressure, as NSAIDs can worsen hypertension 3
  • For long-term use, periodic monitoring of renal function, liver function, and fecal occult blood is recommended 3
  • Discontinue naproxen if GI bleeding, significant elevation in liver enzymes, or worsening hypertension develops 3

Drug Interactions

  • Use caution when combining with anticoagulants, as this significantly increases bleeding risk 3
  • Avoid concurrent use with other NSAIDs or aspirin 3
  • Be aware of potential interactions with lithium, methotrexate, and probenecid 7

Common Pitfalls to Avoid

  • Exceeding recommended dosages, which increases risk of adverse effects without necessarily improving efficacy 2
  • Using in late pregnancy (last 6-8 weeks), which can cause complications including premature closure of the ductus arteriosus 3
  • Failing to recognize that dyspeptic symptoms don't always correlate with clinically significant ulcerations 3
  • Using in patients with pre-existing renal disease, congestive heart failure, or cirrhosis without careful monitoring 3

By following these guidelines, patients can maximize the benefits of naproxen while minimizing potential risks associated with its use.

References

Guideline

Naproxen Dosing and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pharmacokinetics of naproxen sodium.

Cephalalgia : an international journal of headache, 1986

Research

Clinical pharmacokinetics of naproxen.

Clinical pharmacokinetics, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.